To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.

Cost and committee reports

Official records Congress.gov attaches to H.R. 1843.

• Constitutional authority statementThe sponsor’s statement of where the Constitution gives Congress the power to pass this bill. Statement by Mr. DUNN of Florida, as printed in the Congressional Record (Vol. 171, No. 42, March 5, 2025, Page H1009):
  Clause 3 of Section 8 of Article I of the Constitution
  Source: Congress.gov, Congressional Record March 5, 2025 ↗

  Evidence

  Field in the Congress.gov record

  constitutionalAuthorityStatementText

  Statement length

  54 characters

  Congress.gov bill record

  H.R. 1843, 119th Congress

  Congress.gov API record

  https://api.congress.gov/v3/bill/119/hr/1843

  Record last updated by Congress.gov

  February 5, 2026

  PORKER copy retrieved

  September 13, 2026

  Stored copy, SHA-256 of the file

  6349ca2fece56045607a2e57d3f87b97e885e58e465a35c739be38f5bd50b0df

  PORKER shows the statement exactly as printed, with the page markup removed. It is the sponsor’s claim; it is not a legal finding.

Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of February 5, 2026). Not every bill gets one.

From the Congress.gov bill record for H.R. 1843, last updated February 5, 2026. PORKER’s copy was retrieved September 13, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.